NASDAQ:ADAG

Adagene (ADAG) News Today

$1.43

-0.10 (-6.54%)

(As of 10/2/2023 ET)

Compare

Today's Range: $1.41
▼
$1.68
50-Day Range: $1.14
▼
$1.53
52-Week Range: $0.90
▼
$2.10

Volume: 23,995 shs
Average Volume: 7,797 shs
Market Capitalization: $62.68 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.00

Source

Source	Headline
	Short Interest in Adagene Inc. (NASDAQ:ADAG) Decreases By 14.0% americanbankingnews.com - September 30 at 3:58 AM
	Adagene (NASDAQ:ADAG) Stock Price Down 3% americanbankingnews.com - September 23 at 2:40 AM
	Potential Upside For Adagene Inc. (NASDAQ:ADAG) Not Without Risk finance.yahoo.com - September 9 at 5:42 PM
	Adagene to Present at Investor and Scientific Conferences in September finance.yahoo.com - September 7 at 8:43 AM
	Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update finance.yahoo.com - August 31 at 8:45 AM
	Artificial Intelligence (AI) in Drug Discovery Market Revenue To Surpass USD 11,914 Million By 2030 benzinga.com - August 8 at 6:37 PM
	Advances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New Report finance.yahoo.com - July 21 at 10:26 AM
	H.C. Wainwright Sticks to Its Buy Rating for LAVA Therapeutics (LVTX) markets.businessinsider.com - June 12 at 4:21 PM
	Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com - May 25 at 3:19 PM
	Analysts Are Bullish on These Healthcare Stocks: Poseida Therapeutics (PSTX), Mustang Bio (MBIO) markets.businessinsider.com - May 23 at 8:22 AM
	Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody® Novel Masked Antibody-Drug Conjugate finance.yahoo.com - May 4 at 1:23 PM
	Adagene Announces Updates to its Board of Directors finance.yahoo.com - April 28 at 9:33 AM
	HC Wainwright & Co. Reiterates Adagene Inc - ADR (ADAG) Buy Recommendation msn.com - April 22 at 8:54 AM
	Expert Ratings for Adagene markets.businessinsider.com - April 21 at 7:57 PM
	Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid Tumors finance.yahoo.com - April 18 at 12:57 PM
	Are Medical Stocks Lagging Adagene (ADAG) This Year? msn.com - March 31 at 4:41 PM
	Are Medical Stocks Lagging Adagene (ADAG) This Year? finance.yahoo.com - March 31 at 4:41 PM
	Adagene Full Year 2022 Earnings: US$1.85 loss per share (vs US$1.83 loss in FY 2021) finance.yahoo.com - March 31 at 9:52 AM
	Adagene Inc.: Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update finanznachrichten.de - March 29 at 4:43 PM
	Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update finance.yahoo.com - March 28 at 7:00 PM
	H.C. Wainwright Sticks to Its Buy Rating for Adagene (ADAG) markets.businessinsider.com - March 21 at 8:09 AM
	H.C. Wainwright Keeps Their Buy Rating on Hookipa Pharma (HOOK) markets.businessinsider.com - March 16 at 8:42 AM
	Adagene Announces Poster Presentations on Anti-CTLA-4 SAFEbody®, ADG126, at Upcoming American Association for Cancer Research (AACR) Annual Meeting in April finance.yahoo.com - March 14 at 9:06 PM
	Short Interest in Adagene Inc. (NASDAQ:ADAG) Decreases By 63.9% marketbeat.com - January 18 at 5:05 AM
	Adagene Announces Interim Data Demonstrating Safety and Confirmed Clinical Responses of Anti-CTLA-4 SAFEbody® ADG126 up to 10 mg/kg with Repeat Cycles in Combination with Anti-PD-1 Therapy from Dose Escalation Portion of Phase 1b/2 Trial finance.yahoo.com - January 9 at 9:22 AM
	Adagene to Present at the Biotech Showcase™ 2023 in San Francisco on January 9 finance.yahoo.com - January 5 at 6:53 PM
	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC) and Adagene (ADAG) markets.businessinsider.com - December 22 at 8:49 AM
	After One-Off Cash Infusions, YZY Biopharma Looks for More Funds From IPO benzinga.com - December 19 at 11:44 AM
	Adagene adds 12% on clinical trial collaboration with Roche seekingalpha.com - December 16 at 11:40 AM
	Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer finance.yahoo.com - December 16 at 6:40 AM
	Adagene Appoints Cuong Do to Board of Directors and Audit Committee finance.yahoo.com - November 21 at 5:15 PM
	DelveInsight Highlights Major Advances, Transformative Therapies and 180+ Leading Players Wheeling the PD-1 and PD-L1 Inhibitors Pipeline Landscape finance.yahoo.com - November 14 at 11:28 AM
	Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 NEObody™, ADG116, Showing Differentiated Safety and Anti-tumor Activity in Heavily Pre-treated Patients with Difficult-to-Treat Tumors finance.yahoo.com - November 10 at 4:20 PM
	Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody™, ADG116, at Upcoming Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in November finance.yahoo.com - October 11 at 7:21 PM
	Adagene Presents Interim Monotherapy Data at ESMO 2022 Showing Compelling Safety, Anti-Tumor Activity and Pharmacokinetics of Masked, Anti-CTLA-4 SAFEbody® ADG126 in Patients with Advanced Tumors finance.yahoo.com - September 10 at 6:42 AM
	Amazon just slashed prices on classroom essentials — stock up on any last-minute necessities yahoo.com - September 2 at 12:18 AM
	Healee Lands $2M to Grow Customizable Telehealth Solution in the U.S. nz.finance.yahoo.com - September 1 at 4:06 AM
	12 New Trader Joe's Hacks You Need to Try, According to Employees yahoo.com - August 31 at 11:06 PM
	Clearco cuts international staff as it retracts presence, announces new partner yahoo.com - August 31 at 6:05 PM
	JW (Cayman) Therapeutics Co. Ltd. wsj.com - August 30 at 10:00 PM
	Adagene Reports Financial Results for the Six Months Ended June 30, 2022 and Provides Corporate Updates finance.yahoo.com - August 30 at 10:00 PM
	Global CD47 Inhibitor Drug Clinical Trial Report... benzinga.com - August 26 at 1:20 AM
	Adagene Inc. (ADAG) finance.yahoo.com - August 25 at 12:17 AM
	Micro-cap Adagene surges after hours on $10M share buyback seekingalpha.com - July 1 at 5:02 AM
	Adagene ADSs Rise 16% After Co. Announces Repurchase Plan marketwatch.com - June 29 at 10:37 PM
	Adagene Announces Authorization of Share Repurchase Program up to US$10 Million finance.yahoo.com - June 29 at 5:36 PM
	China’s Economy, Geopolitical Risk and Zero Covid Policies nasdaq.com - June 26 at 3:57 PM
	China's Economy, Geopolitical Risk, And Zero Covid Policies seekingalpha.com - June 23 at 3:11 PM
	Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels finance.yahoo.com - May 26 at 8:35 PM
	Biotech and Delisting Risk From China’s Perspective with WisdomTree nasdaq.com - May 19 at 11:23 PM

Get Adagene News Delivered to You Automatically

ADAG Media Mentions By Week

ADAG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ADAG
News Sentiment
▼
1.29

0.70
▲
Average
Medical
News Sentiment

ADAG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ADAG Articles
This Week
▼
3

0
▲
ADAG Articles
Average Week

Get Adagene News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ADAG) was last updated on 10/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Adagene (ADAG) News Today

ADAG Media Mentions By Week

ADAG Media Sentiment

ADAG News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info